The LDN Basics
What Is Low-Dose Naltrexone (LDN)?
Low-Dose Naltrexone (LDN) refers to naltrexone prescribed at a fraction of its standard dose, usually defined in research as 1 to 5 mg a day rather than the 50 mg used for its approved indications, opioid and alcohol dependence. At these low doses, clinicians and researchers have explored a different set of possible effects, centered on immune modulation, inflammation, and overall wellness.
Naltrexone itself is a well-established medication. What makes LDN distinct is the dose and the intent: it is used off-label, meaning outside its original FDA-approved purpose, under the supervision of a qualified provider. Off-label prescribing is a common, legal, and long-standing practice in medicine when evidence and clinical judgment support it.
At Protocol Health, our physician-led team in Scarsdale, NY treats LDN as one carefully considered tool within a broader, individualized plan, never a one-size-fits-all prescription. This guide is educational and is not medical advice; whether LDN is appropriate is always determined case by case with a qualified provider.
Explore Low-Dose Naltrexone at Protocol HealthQuick Answer
What Does Low-Dose Naltrexone Do?
Low-Dose Naltrexone is thought to work by briefly and partially blocking opioid receptors, which may prompt the body to increase its own natural endorphins and dampen certain inflammatory signals. Researchers have studied it most in fibromyalgia and other chronic pain conditions, with smaller reports in Crohn's disease and multiple sclerosis. The trial results are mixed, and the largest fibromyalgia trial so far was negative.
LDN is not a cure, it is not approved to treat these conditions, and responses vary widely from person to person. It is prescribed and monitored by a provider, often alongside relevant lab work, so the approach can be tailored and adjusted over time.
How It Works
How does Low-Dose Naltrexone work in the body?
Low-dose naltrexone is thought to work in the body mainly through what is sometimes called the rebound effect. By transiently and partially binding opioid receptors for a few hours, LDN may signal the body to upregulate its own endorphins and enkephalins, the natural compounds involved in mood, comfort, and immune regulation.
A second proposed mechanism involves glial cells in the nervous system. Research suggests LDN may modulate microglial activity and influence certain inflammatory signals, which is one reason it has drawn interest for conditions where neuroinflammation and immune signaling play a role.
It is worth being clear-eyed: much of the research is early-stage or small in scale, and the mechanisms are still being clarified. This is why LDN is best explored within a supervised, evidence-aware plan rather than as a self-directed experiment.
Potential Benefits
What is LDN studied for?
LDN has been studied in several areas: fibromyalgia and other chronic pain syndromes, and, in smaller clinical reports, inflammatory and autoimmune-related conditions such as Crohn's disease and multiple sclerosis. There is no clinical evidence that LDN extends lifespan or slows aging.
Some people ask about LDN for brain fog, low energy, or slow recovery. Trial evidence for those uses is thin: in the 2013 fibromyalgia trial, LDN did not improve fatigue or sleep. Those symptoms deserve a fuller workup first.
To be careful here: LDN is not proven to diagnose, cure, or prevent any disease, and it should never replace established treatments a specialist has recommended. If you are exploring it for a specific condition, that conversation belongs with a qualified provider who can review your full history and current medications.
The Evidence
Low-Dose Naltrexone Benefits: What the Trials Actually Show
The honest summary of low-dose naltrexone benefits is promising but unproven. A 2018 review in Medical Sciences describes LDN, usually defined as 1 to 5 mg a day, as reducing glial inflammatory signalling through Toll-like receptor 4 and transiently raising the body's own opioid signalling, and lists clinical reports of possible benefit in fibromyalgia, Crohn's disease, multiple sclerosis and complex regional pain syndrome. The same review stresses that these low-dose effects have been only recently and still scarcely studied.
Fibromyalgia is where low dose naltrexone for pain has been tested most directly, and the results point in both directions. In a small 2013 crossover trial in Arthritis & Rheumatism, 31 women with fibromyalgia had a 28.8% reduction in daily pain on 4.5 mg of LDN versus 18.0% on placebo, with better mood and life satisfaction but no change in fatigue or sleep. A larger 2024 randomised trial in The Lancet Rheumatology gave 99 Danish women 6 mg or placebo for 12 weeks and found no meaningful difference in pain, with adverse events reported about equally in both groups.
So the fair reading is that LDN helps some people and not others, and that the best-designed trial so far was negative for its main outcome. Naltrexone is FDA-approved, but not for any of these uses, so LDN is prescribed off-label. Low doses are usually made as a compounded capsule, and compounded preparations are not FDA-approved. At Protocol Health, that evidence is part of the consult: a physician weighs it against your history, medications and goals before deciding whether a monitored trial of LDN makes sense.
Candidacy
Who is a candidate for LDN?
Potential candidates are adults who have a clear reason to consider LDN, realistic expectations, and a provider willing to monitor them. Because naltrexone interacts with opioid medications, LDN is generally not appropriate for anyone currently taking opioid pain medication, and full disclosure of your medication list is essential.
Suitability is determined through consultation and, where appropriate, lab work. Your provider will weigh your symptoms, medical history, current medications, and goals before deciding whether LDN may fit, and at what starting dose.
Many patients who explore LDN are also looking at the bigger picture of energy, inflammation, and healthy aging. In those cases, it may be considered alongside a comprehensive assessment rather than in isolation.
Safety
Is LDN safe? Side effects and precautions
LDN's safety record at low doses shows it was well tolerated in trials, with mostly mild side effects and one key precaution around opioid use. At low doses, LDN has been well tolerated in trials: in the 2013 fibromyalgia trial it was rated as tolerable as placebo, and in the 2024 trial adverse events were about as common on LDN as on placebo. Described side effects tend to be mild. The most commonly reported are vivid dreams or temporary sleep disturbance, mild headache, or brief digestive upset when starting, which is one reason prescribers often start low and adjust gradually.
The most important safety consideration is opioid use. Because naltrexone blocks opioid receptors, combining it with opioid pain medications can be dangerous. Anyone using or anticipating opioid medication, including for surgery, must tell their provider in advance.
As with any medication, individual responses differ, and interactions or contraindications can exist. This is precisely why LDN should be prescribed and monitored by a licensed clinician rather than obtained without oversight. This section is educational and not a substitute for personalized medical advice.
The Experience
What to expect when starting LDN
What to expect when starting LDN is a consultation first to review your history, goals, and medications, often paired with relevant labs so your provider has a clear baseline. From there, a personalized starting dose may be prescribed, frequently low with a plan to titrate upward.
LDN is usually taken once a day. Your prescriber sets the dose and timing and adjusts them based on how you respond. Because any effects can be gradual, patients are generally asked to give it a fair trial period while checking in with their care team.
Follow-up matters. Your provider will review how you feel, revisit labs when appropriate, and fine-tune the plan, discontinuing if it is not the right fit. This iterative, monitored approach is central to using LDN responsibly.
Our Approach
The Protocol Health approach to LDN
Protocol Health is a family-owned, physician-led clinic in Scarsdale, NY. Patients are seen in person at the Scarsdale clinic and by telehealth across New York, New Jersey, Connecticut, Florida and California. Our team treats LDN the way we treat every therapy: individualized, lab-informed, and delivered by real clinicians who know your history.
The Protocol Health LDN consultation starts with your medication list, because opioid use rules LDN out. Rather than prescribing in a vacuum, we consider LDN within a fuller picture of your energy, inflammation, hormones, and longevity goals. For many patients that means starting with a thoughtful assessment before deciding whether LDN, or another path, makes sense.
If you are curious whether Low-Dose Naltrexone could fit your goals, the next step is a conversation with our clinical team. We will help you understand the evidence, the tradeoffs, and the plan, so any decision is made with clarity and proper physician supervision.
FAQ
Frequently Asked Questions
What is Low-Dose Naltrexone used for?
LDN is used off-label and has been studied mainly for fibromyalgia and other chronic pain, with smaller reports in inflammatory and autoimmune-related conditions. Results are mixed. It is not FDA-approved for these purposes and does not diagnose, cure, or prevent disease. A qualified provider determines whether it may be appropriate for you.
How long does LDN take to work?
Responses vary widely, and some people may notice no change at all. When effects do occur, some people report them within a few weeks, while others need a longer, monitored trial period before evaluating benefit. Because doses are often titrated gradually, your provider will typically ask you to check in over time before deciding whether to continue.
Can I take LDN with other medications?
It depends on your full medication list. The most important interaction is with opioid pain medications, which should not be combined with naltrexone. Always share every medication and supplement you take with your provider so they can assess safety before prescribing.
Does LDN have side effects?
At low doses LDN is generally reported to be well tolerated, with the most commonly described effects being vivid dreams or temporary sleep changes, mild headache, or brief digestive upset when starting. Starting low and adjusting gradually may help minimize these. Individual responses differ, which is why physician supervision matters.
Is LDN safe for long-term use?
Long-term safety data are limited: the published trials ran for weeks to months, not years. Some patients use LDN over longer periods under supervision. Long-term suitability is decided case by case, with periodic follow-up and, where appropriate, lab review by your clinical team.
Do I need lab work before starting LDN?
Often, yes. Relevant labs can help your provider establish a baseline, understand contributing factors, and personalize the plan. At Protocol Health, LDN is approached in a lab-informed, individualized way rather than as a blanket prescription.
Explore